{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T11:52:13Z","timestamp":1774353133476,"version":"3.50.1"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The aim of the study was to evaluate the association of high-resolution computed tomography (HRCT) findings with pulmonary fibrotic activity in the corresponding regions using [<jats:sup>68<\/jats:sup>Ga]Ga\u2013fibroblast activation fibroblast inhibitor (FAPI) PET\/CT in patients with interstitial lung disease (ILD). Additionally, the potential of [<jats:sup>68<\/jats:sup>Ga]Ga-FAPI-46 PET\/CT for evaluating the active fibrosis process and <jats:sup>99m<\/jats:sup>Tc-MIBI scintigraphy for assessing the inflammatory process in ILD patients was also assessed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this pilot study, 20 ILD patients underwent [<jats:sup>68<\/jats:sup>Ga]Ga-FAPI-46 PET\/CT and <jats:sup>99m<\/jats:sup>Tc-MIBI SPECT\/CT. Additionally, 10 patients without lung or thoracic involvement who were undergoing [<jats:sup>68<\/jats:sup>Ga]Ga-FAPI PET\/CT for cancer detection were enrolled in the control group. The images were evaluated both visually and semiquantitatively and also compared with HRCT and pulmonary function tests. Multiple quantitative parameters were derived from the lung segments in the PET scan, including SUV<jats:sub>max<\/jats:sub>, SUV<jats:sub>mean<\/jats:sub>, maximum target-to-liver ratio, mean target-to-liver ratio (TLR<jats:sub>mean<\/jats:sub>), and total lesion FAPI expression for the entire lung, as well as its lobes and zones. Additionally, the maximum Hounsfield unit (HU) and mean HU in HRCT were calculated for the whole lung as well as its lobes and zones. Furthermore, an HRCT fibrosis score (HFS) was defined according to the HRCT findings.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Twenty ILD patients with a mean age of 58.70 (SD, 11.09) years were enrolled. Additionally, 10 control patients were enrolled with a mean age of 57.70 (SD, 15.19) years. Based on visual assessment, the FAPI scan was positive in 12 (60%) patients. Similarly, the MIBI scan was positive in 12 (60%) patients. In the 20 ILD cases, both scans were positive in 6 cases, and both were negative in 2 cases. Six cases showed FAPI-negative and MIBI-positive results, whereas another 6 cases showed FAPI-positive and MIBI-negative results. Comparing the control and ILD patients, there was a significant difference in SUV<jats:sub>max<\/jats:sub>, SUV<jats:sub>mean<\/jats:sub>, total lesion FAPI expression, TLR<jats:sub>mean<\/jats:sub>, maximum HU, and mean HU (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05). When comparing HFS with PET-derived parameters in zones, a significant positive correlation was found between HFS and SUV<jats:sub>mean<\/jats:sub>, SUV<jats:sub>max<\/jats:sub>, maximum target-to-liver ratio, and TLR<jats:sub>mean<\/jats:sub> (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05). Additionally, a significant difference was noted between FAPI results and HFS (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.003). An ancillary finding, 9 of 20 (45%) ILD patients showed intense FAPI uptakes in gallbladder, whereas none of the 10 in the control group showed such uptake.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The present study may suggest that combining [<jats:sup>68<\/jats:sup>Ga]Ga-FAPI PET\/CT and <jats:sup>99m<\/jats:sup>Tc-MIBI SPECT\/CT yields an additive effect for evaluating ILD-related fibrosis and inflammatory processes over using either modality alone. Furthermore, it appears that [<jats:sup>68<\/jats:sup>Ga]Ga-FAPI PET\/CT has the potential to ascertain levels of fibrotic activity from population of resident fibroblasts, active fibroblasts, and scar maturation among ILD patients based on their HRCT patterns.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000005505","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T13:47:12Z","timestamp":1728568032000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Exploring the Potential Value of [68Ga]Ga-FAPI-46 PET\/CT for Molecular Assessment of Fibroblast Activation in Interstitial Lung Disease"],"prefix":"10.1097","author":[{"given":"Mehrzad","family":"Bahtouee","sequence":"first","affiliation":[{"name":"Divisions of Respiratory and Critical Care Medicine, Department of Internal Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esmail","family":"Jafari","sequence":"additional","affiliation":[{"name":"The Persian Gulf Nuclear Medicine Research Center, Department of Nuclear Medicine, Molecular Imaging and Theranostics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Khazaei","sequence":"additional","affiliation":[{"name":"Department of Radiology, Bushehr Medical University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahid","family":"Aram","sequence":"additional","affiliation":[{"name":"Divisions of Respiratory and Critical Care Medicine, Department of Internal Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azam","family":"Amini","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine (Division of Rheumatology), Bushehr Medical University Hospital, School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narges","family":"Jokar","sequence":"additional","affiliation":[{"name":"The Persian Gulf Nuclear Medicine Research Center, Department of Nuclear Medicine, Molecular Imaging and Theranostics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hojjat","family":"Ahmadzadehfar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Gholamrezanezhad","sequence":"additional","affiliation":[{"name":"Department of Radiology, Keck School of Medicine, University of Southern California (USC), Los Angeles, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majid","family":"Assadi","sequence":"additional","affiliation":[{"name":"The Persian Gulf Nuclear Medicine Research Center, Department of Nuclear Medicine, Molecular Imaging and Theranostics"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,10,10]]},"reference":[{"key":"bib1-20250206","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2213-0802-2-4","article-title":"Diagnosis and management of interstitial lung disease","volume":"2","year":"2014","journal-title":"Transl Respir Med"},{"key":"bib2-20250206","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra1705751","article-title":"Idiopathic pulmonary fibrosis","volume":"378","year":"2018","journal-title":"N Engl J Med"},{"key":"bib3-20250206","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-0033-1363458","article-title":"High-resolution CT of interstitial lung disease: a continuous evolution","volume":"35","year":"2014","journal-title":"Semin Respir Crit Care Med"},{"key":"bib4-20250206","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/resp.12531","article-title":"HRCT of fibrosing lung disease","volume":"20","year":"2015","journal-title":"Respirology"},{"key":"bib5-20250206","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12916-015-0479-0","article-title":"Relationship between fibroblastic foci profusion and high resolution CT morphology in fibrotic lung disease","volume":"13","year":"2015","journal-title":"BMC Med"},{"key":"bib6-20250206","first-page":"1605","article-title":"Initial results with [18F] FAPI-74 PET\/CT in idiopathic pulmonary fibrosis","volume":"51","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib7-20250206","doi-asserted-by":"crossref","first-page":"e2082","DOI":"10.1097\/MD.0000000000002082","article-title":"99mTc-MIBI lung scintigraphy in the assessment of pulmonary involvement in interstitial lung disease and its comparison with pulmonary function tests and high-resolution computed tomography: a preliminary study","volume":"94","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"bib8-20250206","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1007\/s12350-020-02197-y","article-title":"Increased lung signal as a hint of COVID-19 infection on Tc-99m-sestamibi myocardial perfusion scintigraphy","volume":"28","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"bib9-20250206","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00003072-199801000-00007","article-title":"Abnormal uptake of Tc-99m MIBI, a novel myocardial imaging agent, in the lungs of patients with systemic sclerosis","volume":"23","year":"1998","journal-title":"Clin Nucl Med"},{"key":"bib10-20250206","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13075-021-02578-9","article-title":"The lungs were on fire: a pilot study of 18F-FDG PET\/CT in idiopathic-inflammatory-myopathy\u2013related interstitial lung disease","volume":"23","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"bib11-20250206","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.21873\/invivo.11399","article-title":"Impact of FDG-PET on the detection of patients with lung cancer at high risk for ILD","volume":"32","year":"2018","journal-title":"In Vivo"},{"key":"bib12-20250206","doi-asserted-by":"crossref","first-page":"923869","DOI":"10.3389\/fimmu.2022.923869","article-title":"Positron emission tomography to improve assessment of interstitial lung disease in patients with systemic sclerosis eligible for autologous stem cell transplantation","volume":"13","year":"2022","journal-title":"Front Immunol"},{"key":"bib13-20250206","doi-asserted-by":"crossref","first-page":"538","DOI":"10.2967\/jnumed.108.057901","article-title":"Idiopathic pulmonary fibrosis and diffuse parenchymal lung disease: implications from initial experience with 18F-FDG PET\/CT","volume":"50","year":"2009","journal-title":"J Nucl Med"},{"key":"bib14-20250206","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1016\/S2665-9913(20)30421-5","article-title":"(68)Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis\u2013associated interstitial lung disease: a single-centre, pilot study","volume":"3","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"bib15-20250206","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1007\/s00259-022-05814-9","article-title":"[68Ga]Ga-FAPI-46 PET for non-invasive detection of pulmonary fibrosis disease activity","volume":"49","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib16-20250206","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2967\/jnumed.121.261925","article-title":"Fibroblast activation protein-specific PET\/CT imaging in fibrotic interstitial lung diseases and lung cancer: a translational exploratory study","volume":"63","year":"2022","journal-title":"J Nucl Med"},{"key":"bib17-20250206","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1097\/RLU.0000000000003810","article-title":"Feasibility and therapeutic potential of 177Lu\u2013fibroblast activation protein inhibitor\u201346 for patients with relapsed or refractory cancers: a preliminary study","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib18-20250206","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1164\/rccm.202110-2414OC","article-title":"Comprehensive analysis of fibroblast activation protein expression in interstitial lung diseases","volume":"207","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"bib19-20250206","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.3390\/ph16101434","article-title":"(99m)Tc-Labeled FAPI SPECT imaging in idiopathic pulmonary fibrosis: preliminary results","volume":"16","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"bib20-20250206","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in progressive fibrosing interstitial lung diseases","volume":"381","year":"2019","journal-title":"N Engl J Med"},{"key":"bib21-20250206","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1465-9921-15-10","article-title":"High-resolution CT scoring system-based grading scale predicts the clinical outcomes in patients with idiopathic pulmonary fibrosis","volume":"15","year":"2014","journal-title":"Respir Res"},{"key":"bib22-20250206","first-page":"e14619","article-title":"99mTc-IgG-lung scintigraphy in the assessment of pulmonary involvement in interstitial lung disease and its comparison with pulmonary function tests and high-resolution computed tomography: a preliminary study","volume":"12","year":"2015","journal-title":"Iran J Radiol"},{"key":"bib23-20250206","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S2213-2600(17)30122-4","article-title":"Clinical trial research in focus: why do so many clinical trials fail in IPF?","volume":"5","year":"2017","journal-title":"Lancet Respir Med"},{"key":"bib24-20250206","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2967\/jnumed.121.262944","article-title":"Perspective on fibroblast activation protein-specific PET\/CT in fibrotic interstitial lung diseases: imaging fibrosis\u2014a new paradigm for molecular imaging?","volume":"63","year":"2022","journal-title":"J Nucl Med"},{"key":"bib25-20250206","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1136\/annrheumdis-2020-217408","article-title":"Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging","volume":"79","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"bib26-20250206","doi-asserted-by":"crossref","first-page":"e222389","DOI":"10.1148\/radiol.222389","article-title":"Evaluation of intestinal fibrosis with (68)Ga-FAPI PET\/MR enterography in Crohn disease","volume":"307","year":"2023","journal-title":"Radiology"},{"key":"bib27-20250206","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1007\/s11739-023-03327-3","article-title":"Assessment of pulmonary fibrosis induced by paraquat using Al(18)F-NODA-FAPI-04 PET\/CT","volume":"18","year":"2023","journal-title":"Intern Emerg Med"},{"key":"bib28-20250206","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/rheumatology\/kez483","article-title":"The quantitative assessment of interstitial lung disease with positron emission tomography scanning in systemic sclerosis patients","volume":"59","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"bib29-20250206","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s11604-021-01120-w","article-title":"Ground-glass opacity (GGO): a review of the differential diagnosis in the era of COVID-19","volume":"39","year":"2021","journal-title":"Jpn J Radiol"},{"key":"bib30-20250206","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S2213-2600(20)30168-5","article-title":"Interstitial lung abnormalities detected incidentally on CT: a position paper from the Fleischner Society","volume":"8","year":"2020","journal-title":"Lancet Respir Med"},{"key":"bib31-20250206","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1007\/s00259-022-05720-0","article-title":"A case of [(68)Ga]Ga-FAPI-46\u2013avid and [(18)F]F-FDG-negative COVID-19 pneumonia sequelae","volume":"49","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib32-20250206","first-page":"e20200096","article-title":"Importance of chest HRCT in the diagnostic evaluation of fibrosing interstitial lung diseases","volume":"47","year":"2021","journal-title":"J Bras Pneumol"},{"key":"bib33-20250206","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1513\/AnnalsATS.201807-443OC","article-title":"Computed tomography honeycombing identifies a progressive fibrotic phenotype with increased mortality across diverse interstitial lung diseases","volume":"16","year":"2019","journal-title":"Ann Am Thorac Soc"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005505","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T18:01:21Z","timestamp":1738864881000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005505"}},"subtitle":["A Single-Center Pilot Study"],"short-title":[],"issued":{"date-parts":[[2024,10,10]]},"references-count":33,"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005505","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,10]]}}}